Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Bioequivalence: Overview01:16

Bioequivalence: Overview

975
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
975
Case Studies01:22

Case Studies

11.6K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.6K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Overwhelming Post-Splenectomy Sepsis From Capnocytophaga canimorsus.

International journal of laboratory hematology·2026
Same author

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

The Lancet. Haematology·2026
Same author

Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report.

Case reports in medicine·2026
Same author

Generics in science communication: Misaligned interpretations across laypeople, scientists, and large language models.

Public understanding of science (Bristol, England)·2026
Same author

Clinical outcomes in triple-negative myeloproliferative neoplasms with extreme thrombocytosis: a case series.

Leukemia & lymphoma·2026
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026

相关实验视频

Updated: Jun 21, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

临床试验中的概括 - - 通用药能帮助还是伤害?

Benjamin Chin-Yee

    Kennedy Institute of Ethics journal
    |July 8, 2024
    PubMed
    概括
    此摘要是机器生成的。

    医学研究的概括,通常用作仿制药,风险误解. 为了避免沟通"滑落",在公共医疗环境中避免通用声明,并在私人医生与患者互动中谨慎使用它们.

    更多相关视频

    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.4K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K

    相关实验视频

    Last Updated: Jun 21, 2025

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    00:04

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    10.6K
    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.4K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K

    科学领域:

    • 科学哲学的哲学科学哲学
    • 医学伦理 医学伦理
    • 语言学的语言学.

    背景情况:

    • 医学研究中的概括是常见的,但可能会误导.
    • 仿制药是一种缺乏量化器的概括,在临床试验中很普遍.
    • 现有研究强调了各个学科对仿制药的关注.

    研究的目的:

    • 分析临床试验中常见的概括作为自然语言的通用.
    • 在不同背景下诊断医疗仿制药的功能和故障.
    • 提出公共科学传播的新规范.

    主要方法:

    • 分析临床试验中的概括作为仿制药.
    • 将仿制药的概率和上下文特征应用.
    • 检查医学中的沟通语境.

    主要成果:

    • 医学中的通用概括存在误解或"滑动"的高风险.
    • 在各种沟通环境中,通用药的功能和故障不同.
    • 使用仿制药时需要保持警,特别是在公共和私人医疗机构.

    结论:

    • 避免在临床试验等公共环境中对医疗干预的通用声明.
    • 在私人环境中谨慎和警地使用仿制药,例如医生与患者的接触.
    • 该分析提供了警的工具,并提出了临床沟通中的伦理问题.